The question is whether to seek another partner or to buy out the company. One of the benefits of the JV has been the Ranbaxy distribution network. Using another Indian partner would mean a change in this network, and that could compromise earnings Continue Reading...
Eli Lilly entered into a joint venture agreement with Ranbaxy to produce and market pharmaceuticals on the Indian market in the early 1990s. Eight years later, the parties are re-evaluating the venture. Ranbaxy was considering selling its stake and L Continue Reading...
Eli Lilly JV Eli Lilly and Company has maintained a joint venture in India with Ranbaxy Laboratories Limited. Each firm is a leading pharmaceutical company in their respective countries, and though each offer distinctly different cultures, their joi Continue Reading...
